Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Enbrel, and Stelara biosimilars) has shifted distribution from hospitals to retail and specialty pharmacies. Unlike IV-infused biosimilars (which require hospital administration), auto-injectors and ...

Heading into 2025, the chief item on argenx’s agenda is the FDA’s April 10 target action date to decide on the approval of a prefilled syringe version of Vyvgart—also known as efgartigimod ...